Balaji Amines Ltd

Balaji Amines Expands Capacity & Reports Steady Growth 📈 | Key Updates on Revenue, Margins & Future Projects

- Q2 FY2026: Revenue ₹341 Cr | EBITDA ₹67 Cr (19% margin) | PAT ₹37 Cr

- H1 FY2026: Revenue ₹715 Cr | EBITDA ₹131 Cr (18% margin) | PAT ₹74 Cr

- Operational volumes: 26,165 MT in Q2 (amines 7,685 MT, derivatives 8,374 MT, specialty chemicals 10,107 MT)

- Zero-debt status with strong cash position & efficient working capital

- Upcoming projects: DME plant & N-Methyl Morpholine (FY2025-26), acetonitrile expansion (FY2026-27) – all internally funded

- Balaji Specialty Chemicals’ ₹750 Cr expansion: Hydrogen cyanide, sodium cyanide, EDTA (Unit 1 by Sep 2026, Unit 2 by Dec 2026)

- New capacities: Electronic-grade DMC & pharma-grade propylene glycol to boost future performance

- Demand challenges: Pharma & agrichem segments subdued; EV battery production delays impacting DMC/NMP volumes

- Sustainability: 80% manufacturing powered by solar energy

- Focus on high-value products, cost optimization & green chemistry for long-term growth